AKT1 and non-small cell lung carcinoma: Consistent with this, TNS1 overexpression in A549 NSCLC cells elevated p-Akt and p-mTOR levels and enhanced proliferation, while an Akt inhibitor reduced pathway activation and inhibited TNS1-induced cell growth [47].